secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001558370-24-008988
Event type: other_material
Sentiment:  positive
Materiality: 0.40
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IRADIMED uplists to Nasdaq Global Market, trading starts June 14, 2024 under IRMD
--------------------------------------------------------------------------------

- Nasdaq approved transfer from Capital Market to Global Market, effective June 14, 2024.
- Ticker remains 'IRMD'; no stockholder action required.
- CEO Roger Susi highlights continued growth and enhanced visibility from higher listing standards.
- Nasdaq Global Market includes ~1,450 companies with stricter financial and governance requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000155837024008988/0001558370-24-008988-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000155837024008988/irmd-20240605x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-008988

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer